Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance · 4 days ago
Open | 10.68 |
High | 11.73 |
Low | 10.50 |
Mkt Cap | 294.3M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 10.65 |
52 Wk. Low | 3.84 |
52 Wk. High | 14.75 |
Related stocks
American biotechnology company
Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 102.65k | 17.70% ▼ |
Net Income | -25M | - |
Diluted EPS | -1.12 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$1.00 | - |
Q4 2023 | -$1.27 | -$1.12 |
Q3 2023 | -$1.52 | -$1.56 |
S&P 500^GSPC | 5,221.42-1.26 (-0.02%) |
Dow 30^DJI | 39,431.51-81.33 (-0.21%) |
Nasdaq^IXIC | 16,388.24+47.37 (+0.29%) |
30.45+74.40% | |
5.19+78.35% | |
84.60+5.70% |